Drug-resistant Tuberculosis Among Previously Treated Patients in Yangon, Myanmar

Int J Mycobacteriol. 2016 Sep;5(3):366-367. doi: 10.1016/j.ijmyco.2016.06.004. Epub 2016 Jun 23.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Catalase / genetics
  • Catalase / metabolism
  • DNA-Directed RNA Polymerases / genetics
  • DNA-Directed RNA Polymerases / metabolism
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Ethambutol / therapeutic use
  • Female
  • Gene Expression
  • Genome, Bacterial*
  • Humans
  • Isoniazid / therapeutic use
  • Male
  • Middle Aged
  • Mutation
  • Myanmar
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics*
  • Mycobacterium tuberculosis / growth & development
  • Mycobacterium tuberculosis / metabolism
  • Recurrence
  • Rifampin / therapeutic use
  • Sputum / microbiology
  • Streptomycin / therapeutic use
  • Tuberculosis, Multidrug-Resistant / diagnosis*
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / microbiology
  • Tuberculosis, Pulmonary / diagnosis*
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / microbiology
  • Whole Genome Sequencing

Substances

  • Antitubercular Agents
  • Bacterial Proteins
  • rpoB protein, Mycobacterium tuberculosis
  • Ethambutol
  • Catalase
  • katG protein, Mycobacterium tuberculosis
  • DNA-Directed RNA Polymerases
  • Isoniazid
  • Rifampin
  • Streptomycin